{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:39:54Z","timestamp":1794382794278,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":24,"publisher":"Humana Press","isbn-type":[{"value":"9781607618164","type":"print"},{"value":"9781607618171","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-60761-817-1_6","type":"book-chapter","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T18:06:45Z","timestamp":1291054005000},"page":"79-100","source":"Crossref","is-referenced-by-count":1,"title":["The Detection of Hepatitis Viruses"],"prefix":"10.1007","author":[{"given":"Peter","family":"Karayiannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,16]]},"reference":[{"key":"6_CR1_6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/bmb\/ldh024","volume":"70","author":"P Karayiannis","year":"2004","unstructured":"Karayiannis, P., Main, J., and Thomas, H.C. (2004) Hepatitis vaccines. Br Med Bull 70, 29\u201349.","journal-title":"Br Med Bull"},{"key":"6_CR2_6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1128\/CMR.19.1.63-79.2006","volume":"19","author":"OV Nainan","year":"2006","unstructured":"Nainan, O.V., Xia, G., Vaughan, G., and Margolis, H.S. (2006) Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 19, 63\u201379.","journal-title":"Clin Microbiol Rev"},{"key":"6_CR3_6","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1099\/vir.0.19532-0","volume":"84","author":"M Costa-Mattioli","year":"2003","unstructured":"Costa-Mattioli, M., Di Napoli, A., Ferr\u00e9, V., Billaudel, S., Perez-Bercoff, R., and Cristina, J. Genetic variability of hepatitis A virus. J Gen Virol 84, 3191\u20133201.","journal-title":"J Gen Virol"},{"key":"6_CR4_6","doi-asserted-by":"publisher","first-page":"8281","DOI":"10.1073\/pnas.85.21.8281","volume":"85","author":"LH Ping","year":"1988","unstructured":"Ping, L.H., Jansen, R.W., Stapleton, J.T., Cohen, J.I., and Lemon, S.M. (1988) Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci USA 85, 8281\u20138285.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR5_6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem, D. and Prince, A.M. (2004) Hepatitis B virus infection \u2013 natural history and clinical consequences. N Engl J Med 350, 118\u2013129.","journal-title":"N Engl J Med"},{"key":"6_CR6_6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/9780470987131.ch15","volume-title":"Viral Hepatitis","author":"P Karayiannis","year":"2005","unstructured":"Karayiannis, P., Carman, W.F., and Thomas, H.C. (2005) Molecular variations in the core promoter, precore and core regions of hepatitis B virus, and their clinical significance. In: Thomas, H.C., Lemon, S., and Zuckerman, A.J. Ed. Viral Hepatitis. Blackwell, London, pp. 242\u2013262."},{"key":"6_CR7_6","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1053\/j.gastro.2007.02.040","volume":"132","author":"AS Lok","year":"2007","unstructured":"Lok, A.S. (2007) Navigating the maze of hepatitis B treatments. Gastroenterology 132, 1586\u20131594.","journal-title":"Gastroenterology"},{"key":"6_CR8_6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/9780470987131.ch14","volume-title":"Viral Hepatitis","author":"WF Carman","year":"2005","unstructured":"Carman, W.F., Jazayeri, M., Basune, A., Thomas, H.C., and Karayiannis, P. (2005) Hepatitis B surface antigen (HBsAg) vari\u00adants. In: Thomas, H.C., Lemon, S., and Zuckerman, A.J.\u00ad Ed. Viral Hepatitis. Blackwell, London, pp. 225\u2013241."},{"key":"6_CR9_6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrmicro1645","volume":"5","author":"D Moradpour","year":"2007","unstructured":"Moradpour, D., Penin, F., and Rice, C.M. (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5, 453\u2013463.","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"6_CR10_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/135965350801301S04","volume":"13","author":"G Foster","year":"2008","unstructured":"Foster, G. and Mathurin, P. (2008) Hepatitis C virus therapy to date. Antivir Ther 13(Suppl 1), 3\u20138.","journal-title":"Antivir Ther"},{"key":"6_CR11_6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/hep.20819","volume":"42","author":"P Simmonds","year":"2005","unstructured":"Simmonds, P., Bukh, J., Combet, C., Del\u00e9age, G., Enomoto, N., Feinstone, S., Halfon, P., Inchausp\u00e9, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D.G., Okamoto, H., Pawlotsky, J.M., Penin, F., Sablon, E., Shin-I, T., Stuyver, L.J., Thiel, H.J., Viazov, S., Weiner, A.J., and Widell, A. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962\u2013973.","journal-title":"Hepatology"},{"key":"6_CR12_6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.virol.2005.09.033","volume":"344","author":"JM Taylor","year":"2006","unstructured":"Taylor, J.M. (2006) Hepatitis delta virus. Virology 344, 71\u201376.","journal-title":"Virology"},{"key":"6_CR13_6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/3-540-29802-9_8","volume":"307","author":"P D\u00e9ny","year":"2006","unstructured":"D\u00e9ny P. (2006) Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol 307, 151\u2013171.","journal-title":"Curr Top Microbiol Immunol"},{"key":"6_CR14_6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/jmv.21116","volume":"80","author":"IK Mushahwar","year":"2008","unstructured":"Mushahwar, I.K. (2008) Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 80, 646\u2013658.","journal-title":"J Med Virol"},{"key":"6_CR15_6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.virusres.2007.02.002","volume":"127","author":"H Okamoto","year":"2007","unstructured":"Okamoto H. (2007) Genetic variability and evolution of hepatitis E virus. Virus Res 127, 216\u2013228.","journal-title":"Virus Res"},{"key":"6_CR16_6","first-page":"1628","volume":"22","author":"P Karayiannis","year":"1995","unstructured":"Karayiannis, P., Alexopoulou, A., Hadziyannis, S., Thursz, M., Watts, R., Seito, S., and Thomas, H.C. (1995) Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 22, 1628\u20131634.","journal-title":"Hepatology"},{"key":"6_CR17_6","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0140-6736(89)90713-7","volume":"ii","author":"WF Carman","year":"1989","unstructured":"Carman, W.F., Jacyna, M.R., Hadziyannis, S., Karayiannis, P., McGarvey, M., Makris, A., and Thomas, H.C. (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii, 588\u2013591.","journal-title":"Lancet"},{"key":"6_CR18_6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","volume":"ii","author":"WF Carman","year":"1990","unstructured":"Carman, W.F., Zanetti, A.R., Karayiannis, P., Manzillo, G., Tanzi, E., Zuckerman, A.J., and Thomas, H.C. (1990) A vaccine induced escape mutant of hepatitis B virus. Lancet ii, 325\u2013329.","journal-title":"Lancet"},{"key":"6_CR19_6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0","volume":"60","author":"S Seddigh-Tonekaboni","year":"2000","unstructured":"Seddigh-Tonekaboni, S., Waters, J.A., Jeffers, S., Gehrke, R., Ofenloch, B., Horsch, A., Hess, G., Thomas, H.C., and Karayiannis, P. (2000) The effect of variation in the common \u201ca\u201d determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60, 113\u2013121.","journal-title":"J Med Virol"},{"key":"6_CR20_6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1086\/382133","volume":"189","author":"T Yamashiro","year":"2004","unstructured":"Yamashiro, T., Nagayama, K., Enomoto, N., Watanabe, H., Miyagi, T., Nakasone, H., Sakugawa, H., and Watanabe, M. (2004) Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction \u2013 and its possible correlation with the clinical stage of liver disease. J Infect Dis 189, 1151\u20131157.","journal-title":"J Infect Dis"},{"key":"6_CR21_6","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jviromet.2007.07.014","volume":"146","author":"P Gyarmati","year":"2007","unstructured":"Gyarmati, P., Mohammed, N., Norder, H., Blomberg, J., Bel\u00e1k, S., and Wid\u00e9n, F. (2007) Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and primer-probe energy transfer. J Virol Methods 146, 226\u2013235.","journal-title":"J Virol Methods"},{"issue":"Suppl 3","key":"6_CR22_6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1386-6532(02)00195-6","volume":"25","author":"C Sarrazin","year":"2002","unstructured":"Sarrazin, C. (2002) Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance. J Clin Virol 25(Suppl 3), 23\u201329.","journal-title":"J Clin Virol"},{"key":"6_CR23_6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-2006-939758","volume":"26","author":"A Bartholomeusz","year":"2006","unstructured":"Bartholomeusz, A. and Locarnini, S.A. (2006) Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 26, 162\u2013170.","journal-title":"Semin Liver Dis"},{"issue":"Suppl 1","key":"6_CR24_6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/135965350801301S05","volume":"13","author":"DM Jensen","year":"2008","unstructured":"Jensen, D.M. and Ascione, A. (2008) Future directions in therapy for chronic hepatitis C. Antivir Ther 3(Suppl 1), 31\u201336.","journal-title":"Antivir Ther"}],"container-title":["Methods in Molecular Biology","Diagnostic Virology Protocols"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60761-817-1_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T05:33:36Z","timestamp":1685856816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-60761-817-1_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781607618164","9781607618171"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-60761-817-1_6","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-60761-817-1","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}